Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 29, 2012, Pages 11818-11823

  Bhatt, Aadra P ^a,b   Jacobs, Sarah R ^a,b   Freemerman, Alex J ^c   Makowski, Liza ^a,c   Rathmell, Jeffrey C ^d   Dittmer, Dirk P ^a,b   Damania, Blossom ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c University of North Carolina   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Kaposi sarcoma associated herpesvirus; Metabolism

Indexed keywords

FATTY ACID; FATTY ACID SYNTHASE; FATTY ACID SYNTHASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE;

AEROBIC METABOLISM; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; DRUG TARGETING; FATTY ACID ANALYSIS; FATTY ACID SYNTHESIS; GLYCOLYSIS; HUMAN; HUMAN CELL; METABOLIC REGULATION; MOLECULARLY TARGETED THERAPY; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL;

4-BUTYROLACTONE; B-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; GLYCOLYSIS; HUMANS; IMMUNOBLOTTING; LYMPHOMA, B-CELL; LYMPHOMA, PRIMARY EFFUSION; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

HUMAN HERPESVIRUS 8;

EID: 84863964058     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1205995109     Document Type: Article

References (35)

1. Boulanger E, et al. (2005) Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 23:4372-4380. (Pubitemid 46207011)
2. Sin SH, et al. (2007) Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood 109:2165-2173.
3. Bhatt AP, et al. (2010) Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas. Blood 115:4455-4463.
4. Wang L, et al. (2004) The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 64: 2774-2781. (Pubitemid 38500615)
5. Tomlinson CC, Damania B (2004) The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J Virol 78:1918-1927. (Pubitemid 38176723)
6. Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B (2006) Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res 66:3658-3666.
7. Sodhi A, et al. (2004)Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci USA 101:4821-4826. (Pubitemid 38469161)
8. Bais C, et al. (2003) Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR. Cancer Cell 3:131-143. (Pubitemid 37443386)
9. Bhende PM, Park SI, Lim MS, Dittmer DP, Damania B (2010) The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma. Leukemia 24:1781-1784.
10. Manning BD, Cantley LC (2007) AKT/PKB signaling: Navigating downstream. Cell 129:1261-1274. (Pubitemid 46962095)
11. Wieman HL, Wofford JA, Rathmell JC (2007) Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol Biol Cell 18:1437-1446. (Pubitemid 46626638)
12. Elstrom RL, et al. (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64: 3892-3899. (Pubitemid 38697301)
13. Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269-270.
14. Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134:703-707.
15. Young CD, Anderson SM(2008) Sugar and fat - that's where it's at: Metabolic changes in tumors. Breast Cancer Res 10:202.
16. Düvel K, et al. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39:171-183.
17. Kuhajda FP (2000) Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology. Nutrition 16:202-208.
18. Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA (2008) Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Prolif 41:59-85. (Pubitemid 351147647)
19. Flavin R, Peluso S, Nguyen PL, Loda M (2010) Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol 6:551-562.
20. Yoon S, et al. (2007) Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J Biol Chem 282:26122-26131. (Pubitemid 47443806)
21. Yang YA, Han WF, Morin PJ, Chrest FJ, Pizer ES (2002) Activation of fatty acid synthesis during neoplastic transformation: Role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp Cell Res 279:80-90.
22. Kuhajda FP, et al. (2000) Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA 97:3450-3454. (Pubitemid 30183323)
23. Armerding D, Sachs DH, Katz DH (1974) Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor. J Exp Med 140:1717-1722.
24. Teng YW, Mehedint MG, Garrow TA, Zeisel SH (2011) Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas. J Biol Chem 286:36258-36267.
25. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324:1029-1033.
26. Faber AC, et al. (2006) Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas. Biochem Pharmacol 72:1246-1256. (Pubitemid 44572191)
27. Wenzel U, Nickel A, Daniel H (2005) Increased carnitine-dependent fatty acid uptake into mitochondria of human colon cancer cells induces apoptosis. J Nutr 135:1510-1514. (Pubitemid 40799619)
28. Newgard CB, et al. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311-326.
29. Delgado T, et al. (2010) Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc Natl Acad Sci USA 107:10696-10701.
30. Weinstein IB, Joe AK (2006) Mechanisms of disease: Oncogene addiction - a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol 3:448-457. (Pubitemid 44203817)
31. Roy D, Dittmer DP (2011) Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma. Am J Pathol 179:2108-2119.
32. Roskrow MA, et al. (1998) Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood 91:2925-2934. (Pubitemid 28227543)
33. Rathmell JC, Farkash EA, Gao W, Thompson CB (2001) IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 167:6869-6876. (Pubitemid 33144179)
34. Deberardinis RJ, Lum JJ, Thompson CB (2006) Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth. J Biol Chem 281:37372-37380. (Pubitemid 46042041)
35. Reitman ZJ, et al. (2011) Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci USA 108:3270-3275.